clinical trial · NCT07692165
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
Innatus Therapeutics (Shanghai) Co., Ltd.·phase2·recruiting·n = 24
Ulcerative Colitis (UC)INT-210 CapsuleINT-210 Capsule
brief summary
A Multicenter, Randomized, Open-label Clinical Study to Evaluate the Safety and Efficacy of INT-210 Capsules in Participants with Active Ulcerative Colitis. The study aims to evaluate the safety, efficacy, pharmacokinetic (PK) characteristics, pharmacodynamic (PD) characteristics of INT-210 in participants with active ulcerative colitis (UC).
started
Jun 11, 2026
primary completion
Jun 1, 2028
completion
Jun 1, 2028
last updated
Jul 9, 2026
official title
A Multicenter, Randomized, Open-label Clinical Study to Evaluate the Safety and Efficacy of INT-210 Capsules in Participants With Active Ulcerative Colitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol